DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · Real-Time Price · USD

6.53

-0.02 (-0.31%)

At close: Sep 15, 2026, 4:00 PM EDT

6.60

+0.07 (1.07%)

After-hours: Sep 15, 2026, 7:30 PM EDT

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.13	15.65	3.03	4.54	4.73	4.71
Short-Term Investments	38.38	44.24	41.12	48.35	28.77	40.41
Cash & Short-Term Investments	43.5	59.89	44.15	52.9	33.5	45.11
Cash Growth	44.83%	35.66%	-16.54%	57.89%	-25.74%	64.00%
Other Receivables	0.24	0.26	0.24	0.37	0.08	0.13
Receivables	0.24	0.26	0.24	0.37	0.08	0.13
Prepaid Expenses	0.57	0.48	0.23	0.41	0.21	0.08
Other Current Assets	-	-	-	-	0.04	0.11
Total Current Assets	44.32	60.63	44.61	53.68	33.84	45.44
Property, Plant & Equipment	0.29	0.34	0.43	0.49	0.56	0.11
Long-Term Deferred Charges	0.4	0.4	-	-	-	-
Other Long-Term Assets	-	-	1.31	-	-	-
Total Assets	45	61.37	46.35	54.16	34.4	45.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.81	1.48	0.94	0.93	0.73	0.51
Accrued Expenses	3.67	3.55	4.35	1.78	1.37	0.97
Current Portion of Leases	0.12	0.11	0.1	0.08	0.07	0.05
Total Current Liabilities	6.59	5.13	5.39	2.79	2.17	1.52
Long-Term Leases	0.07	0.13	0.24	0.32	0.4	0
Total Liabilities	6.66	5.26	5.63	3.1	2.57	1.53

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	231.32	228.83	180.7	166.61	128.08	126.58
Retained Earnings	-192.95	-172.77	-140	-115.56	-96.18	-82.5
Comprehensive Income & Other	-0.04	0.05	0.02	0.01	-0.07	-0.05
Shareholders' Equity	38.34	56.11	40.72	51.06	31.83	44.02
Total Liabilities & Equity	45	61.37	46.35	54.16	34.4	45.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.19	0.24	0.34	0.4	0.47	0.05
Net Cash (Debt)	43.32	59.65	43.81	52.5	33.03	45.06
Net Cash Growth	45.63%	36.17%	-16.55%	58.92%	-26.69%	64.52%
Net Cash Per Share	0.83	1.27	1.08	1.61	1.25	2.17
Filing Date Shares Outstanding	53.93	53.88	42.86	37.96	26.46	26.44
Total Common Shares Outstanding	53.93	53.74	42.82	37.96	26.44	26.44
Working Capital	37.72	55.5	39.22	50.89	31.67	43.92
Book Value Per Share	0.71	1.04	0.95	1.35	1.20	1.66
Tangible Book Value	38.34	56.11	40.72	51.06	31.83	44.02
Tangible Book Value Per Share	0.71	1.04	0.95	1.35	1.20	1.66
Machinery	0.28	0.28	0.25	0.22	0.2	0.14
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02	0

SEC Filings: 10-K · 10-Q